Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN) [Neutrals]
BHVN Rating Summary
BHVN Price Target Summary
- Highest: $66.00 (Piper Sandler)
- Lowest: $55.00 (TD Cowen)
- Average: $59.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$59.75 (+55%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Avg. $ Target:
$59.75 (+55%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2022 | Wedbush | Laura Chico | Downgrade | Neutral (Outperform) |
148.50 (N/A) |
146.98 (38.54) |
-73.78% | Details |
| 2/10/2020 | Oppenheimer | Esther Rajavelu | Downgrade | Perform (Outperform) |
51.00 (67.00) |
51.25 (38.54) |
-24.8% | Details |
 |
||||||||
|
||||||||
